Bioamber Inc (BIOAQ)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2017 | 12-2016 | 12-2015 | 12-2014 | 12-2013 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 4,632 | 25,057 | 6,974 | 51,043 | 83,728 |
| Receivables | 5,252 | 1,555 | 1,541 | 3,482 | 3,017 |
| Inventories | 4,823 | 4,498 | 1,749 | 1,802 | 2,415 |
| Other current assets | 0 | 0 | 0 | 0 | 671 |
| TOTAL | $15,248 | $31,422 | $10,844 | $57,092 | $94,963 |
| Non-Current Assets | |||||
| PPE Net | 49,461 | 121,628 | 122,543 | 88,665 | 13,554 |
| Investments And Advances | 447 | 447 | 447 | 35 | 710 |
| Intangibles | 4,036 | 6,752 | 6,978 | 4,958 | 4,851 |
| Other Non-Current Assets | 322 | 1,082 | 976 | 1,690 | 0 |
| TOTAL | $54,266 | $129,909 | $130,943 | $95,348 | $19,116 |
| Total Assets | $69,514 | $161,331 | $141,787 | $152,440 | $114,079 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | 4,920 | 23,299 | 10,298 | 2,978 | 6,520 |
| Accounts payable and accrued liabilities | 6,153 | 6,022 | 15,834 | 17,443 | 7,111 |
| Other current liabilities | N/A | 14,497 | N/A | N/A | N/A |
| TOTAL | $11,296 | $45,305 | $29,682 | $22,900 | $17,813 |
| Non-Current Liabilities | |||||
| Long Term Debt | 32,696 | 29,032 | 28,492 | 34,653 | 23,210 |
| Deferred Revenues | 0 | 1,372 | 3,438 | 2,275 | 3,061 |
| Other Non-Current Liabilities | 7,706 | 44,395 | 41,203 | 39,687 | 6,496 |
| TOTAL | $36,366 | $67,535 | $65,750 | $73,465 | $29,132 |
| Total Liabilities | $47,661 | $112,840 | $95,432 | $96,365 | $46,945 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 129,451 | 34,850 | 28,782 | 21,839 | 18,562 |
| Common Shares | 996 | 1,003 | 1,010 | 1,312 | 3,150 |
| Retained earnings | -318,920 | -220,768 | -198,290 | -161,064 | -115,044 |
| Other shareholders' equity | -12,559 | -12,564 | -15,157 | -4,633 | 1,752 |
| TOTAL | $21,853 | $48,491 | $46,355 | $56,076 | $67,134 |
| Total Liabilities And Equity | $69,514 | $161,331 | $141,787 | $152,440 | $114,079 |